Company: Tchaikapharma High Quality Medicines AD (THQM)
The General Meeting of Shareholders of Tchaikapharma High Quality Medicines AD dated 24 June 2026 has decided to distribute a stock dividend (capital increase by own funds) as follows:
- Amount of the capital before the increase: EUR 48,909,000
- Amount of the stock dividend: 5,400,000 shares
- Share capital after the increase: EUR 51,663,000
The right to a stock dividend will be entitled to all shareholders registered with the central securities register on the 14th day following the GMS date, i.e. as of 08 July 2026 (Record Date).
The last date for transacting shares of this company on the Exchange for the shareholder to be entitled to receive a stock dividend will be 06 July 2026 (Ex-Dividend Date: 07 July 2026).
The entire piece of news is available on the financial website X3News.
Notification for distribution of a stock dividend
Summary by 6ix AI
The General Meeting of Shareholders of Tchaikapharma High Quality Medicines AD decided on June 24, 2026 to distribute a stock dividend of 5,400,000 shares, a capital increase paid from the company's own funds.
Key details
- Share capital rises from EUR 48,909,000 before the increase to EUR 51,663,000 after it.
- Shareholders registered with the central securities register as of July 8, 2026 (the record date) are entitled to the stock dividend.
- The last day to trade the shares on the exchange and still receive the stock dividend is July 6, 2026; the shares trade without the dividend right from July 7, 2026 (the ex-dividend date).
6ix AI wrote this summary from the release below and checked it against the release.
On 6ix: 6ix.com/news/tchaikapharma-high-quality-medicines-notification-for-distribution-of-a-stock-dividend
Notification for distribution of a stock dividend
26.06.2026 10:57:44 (local time)
Tchaikapharma High Quality Medicines, Inc. on 6ix
Earlier from Tchaikapharma High Quality Medicines
- Tchaikapharma High Quality Medicines: Financial and other reports (Consolidated quarterly financial report)
- Tchaikapharma High Quality Medicines: Financial and other reports (Quarterly financial report)
- Suspension from trading of registered financial instruments
- Registration of financial instruments
- Invitation and materials for a GSM
Later from Tchaikapharma High Quality Medicines
All Tchaikapharma High Quality Medicines news releasesFollow Tchaikapharma High Quality Medicines into a list and get an email when it puts out news.
Follow Tchaikapharma High Quality Medicines